Progression Of ETS2101 In Brain Cancer
by Robert Sutter
It's clear that there are multiple trials to consider in the name of brain cancer, some of them more recognized than others. However, it's clear that most of them are done over an extended stretch of time, seeing as how details are going to have to be picked up on. I feel as though this is for the best, seeing as how you can't exactly learn much over a day's time. This is especially true when considering the lengthy nature of study of the ETS2101 drug.
The Wall Street Journal posted an article in regards to the ETS2101 trial, which has entailed a number of patients affected with either primary or secondary brain cancer. Each of them was given a particular dose of ETS2101. This was done in order to see how well their bodies would take to it and if they would need larger or smaller amounts. The study will be done through 2014 as well, which means that organizations along the lines of Voices against Brain Cancer should bring their attention towards it.
For those who are unfamiliar with ETS2101, it should be noted that this field is not the only one it's been utilized in. The article said that, in the past, it has been used in order to help patients with cases of trauma. However, with pharmacology set in place, it's been learned that it can help patients with cancer as well. With two ongoing studies being seen - one with patients with primary cancer and the other with patients impacted by secondary cancer - a great deal of dedication has been seen.
Back to the subject of the procedure, though, patients have been treated with gradually higher doses of the drug until a tolerated level has been found. The report said that fifteen patients have completed the study with doses relative to body waste and the results have been generally positive. They took to the ETS2101 drug well and tumors have not responded objectively to the drug in question. It's an instance of success that, in my opinion, can most likely lead to further results seen down the road.
It's easy to understand why these particular studies are done over the course of time, whether it is a matter of a few months or even a few years. Brain cancer is one of the most serious conditions and, as a result, a tremendous amount of focus is brought to the idea of treatment in the long run. Hopefully there is more work done with the ETS2101 drug set in place. In my opinion, there is a world of knowledge to pick up on here.
Contact <a href="http://www.voicesagainstbraincancer.org/">Voices Against Brain Cancer</a> if you are searching for some more information about glioblastoma and brain cancer awareness.. Unique version for reprint here: <a href="http://www.uberarticles.com/home.php?id=1943532&p=56131">Progression Of ETS2101 In Brain Cancer</a>.
---------------------------------------------------
You are receiving this because you signed up for it on 2011-11-27 from IP 188.29.196.69
To fine-tune your selection of which articles to receive, just login here:
http://www.uniquearticlewizard.com/bloggers/
using your username:
To unsubscribe please use the following link:
http://www.uniquearticlewizard.com/unsubscribe.php?mail=nightcabcontroller.sante1@blogger.com&code=f1f5baef192407461ee7ffe7468a92d2
---------------------------------------------------
---------------------------------
New Unique Article!
Title: Progression Of ETS2101 In Brain Cancer
Author: Robert Sutter
Email: seo@fishbat.com
Keywords: voices against brain cancer, brain cancer awareness, brain cancer research, brain tumors, glioblastoma, health
Word Count: 438
Category: Disease & Illness
---------------------------------
No comments:
Post a Comment